Cobamamide

This article delves into a clinical trial investigating the use of Cobamamide, also known as Adenosylcobalamin, in treating malnourished patients. The study aims to evaluate the effectiveness of this supplement in improving various aspects of health and nutrition in individuals suffering from malnutrition. We’ll explore the trial’s design, expected outcomes, and potential implications for future treatments.

Table of Contents

What is Cobamamide?

Cobamamide, also known as adenosylcobalamin or by its brand name Cobazim 3000, is a form of vitamin B12 being studied for its potential benefits in treating malnutrition[1]. Vitamin B12 is an essential nutrient that plays a crucial role in various bodily functions, including the formation of red blood cells and the proper functioning of the nervous system.

Purpose of the Study

Researchers are conducting a clinical trial to investigate the effectiveness of cobamamide supplements in improving the health of malnourished patients[1]. Malnutrition is a condition where a person’s body doesn’t get enough nutrients to function properly, which can lead to various health problems.

How the Study Works

The study is designed to compare the effects of cobamamide with a placebo (a substance with no active ingredients) in malnourished patients[1]. Here’s how it works:

  • Treatment group: Patients in this group receive 3000 mg of cobamamide twice daily for 28 days.
  • Placebo group: Patients in this group receive a placebo capsule twice daily for 28 days.

By comparing the results between these two groups, researchers can determine if cobamamide is effective in treating malnutrition.

Expected Outcomes

The researchers will measure several factors to assess the effectiveness of cobamamide[1]. These include:

  1. Changes in appetite: Using a specialized questionnaire, researchers will evaluate if patients’ appetites improve with cobamamide treatment.
  2. Nutritional status: A comprehensive assessment will be conducted to determine if overall nutritional status improves.
  3. Muscle mass: Changes in muscle mass will be measured using a technique called bioimpedance analysis.
  4. Blood tests: Several blood tests will be performed to assess various aspects of health:
    • Methylmalonic acid levels: This can indicate how well the body is using vitamin B12.
    • Prealbumin levels: This protein can reflect overall nutritional status.
    • Kidney function tests: Measuring urea and creatinine levels in the blood.
    • Liver function tests: Checking ALT and AST levels to assess liver health.
    • Complete blood count: This test provides information about various blood components, including red blood cells, which can be affected by vitamin B12 levels.

Potential Benefits

If cobamamide proves effective, it could offer several benefits for malnourished patients[1]:

  • Improved appetite, potentially leading to better food intake
  • Enhanced overall nutritional status
  • Increased muscle mass, which is often lost in malnourished individuals
  • Better functioning of various body systems due to improved vitamin B12 levels

Safety Considerations

While the study aims to investigate the benefits of cobamamide, it’s important to note that all medical treatments can have potential side effects[1]. The researchers will be monitoring participants closely throughout the study to ensure their safety. The inclusion of liver and kidney function tests suggests that they are particularly interested in ensuring that the supplement doesn’t negatively impact these vital organs.

It’s crucial to remember that cobamamide should only be taken under medical supervision, especially in the high doses used in this study. Patients should not attempt to self-treat malnutrition or take high doses of vitamin B12 supplements without consulting a healthcare provider.

Aspect Details
Study Drug Cobamamide (Adenosylcobalamin)
Condition Studied Malnutrition
Dosage 3000 mg, twice daily
Treatment Duration 28 days
Control Group Placebo
Primary Outcomes Appetite changes, Nutritional status, Muscle mass, Blood test results
Assessment Tools Council on Nutrition Appetite Questionnaire, Subjective Global Assessment, Bioimpedance Analysis

Ongoing Clinical Trials on Cobamamide

  • Study on L-Carnitine and Cobamamide for Patients with Septic Shock and Acute Kidney Injury

    Not recruiting

    3 1 1
    France

Glossary

  • Cobamamide: A form of vitamin B12, also known as Adenosylcobalamin, being studied for its potential benefits in treating malnutrition.
  • Malnutrition: A condition that results from eating a diet lacking in nutrients or eating too little, leading to health problems.
  • Placebo: A substance with no active ingredients used in clinical trials to compare against the effects of the drug being tested.
  • Council on Nutrition Appetite Questionnaire: A tool used to evaluate changes in appetite during the study.
  • Subjective Global Assessment: A form used to assess changes in a patient's nutritional status.
  • Bioimpedance Analysis: A method used to measure body composition, including muscle mass.
  • Methylmalonic Acid: A substance measured in blood tests that can indicate vitamin B12 deficiency.
  • Prealbumin: A protein in the blood that can be measured to assess nutritional status.
  • ALT and AST: Liver enzymes measured in blood tests to check liver function.
  • Complete Blood Count: A blood test that measures various components of the blood, including red and white blood cells and platelets.

References

  1. https://clinicaltrials.gov/study/NCT05944744